Design, Synthesis and Biological Activity of Rigid Cannabinoid CB₁ Receptor Antagonists

Abstract

The design, synthesis and biological activities of potent pyrazole-based tricyclic CB₁ receptor antagonists (2) are described. The key synthetic step involves the ring closure of the lithiated α, γ-keto ester adduct (4). The optimal nitroderivative (28) in this series exhibits a high CB₁ receptor affinity (pK_i=7.2) as well as very potent antagonistic activity (pA₂=8.8) in vitro. The regioselectivity of the pyrazole ring closure is shown to depend strongly on the aromatic substitution pattern of the applied arylhydrazine.